文献库，生知库 | 链接生命科学的每一步

Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein

凝集素与刺突蛋白上的两个聚糖簇结合，导致 SARS-CoV-2 不可逆失活

doi:10.1021/acs.biochem.3c00109

Aakansha Nangarlia, Farah Fazloon Hassen, Gabriela Canziani, Praneeta Bandi, Choya Talukder, Fengwen Zhang, Douglas Krauth, Ebony N Gary, David B Weiner, Paul Bieniasz, Sonia Navas-Martin, Barry R O'Keefe, Charles G Ang, Irwin Chaiken

The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity

工程化的 CD80 变体融合治疗药物达沃西普 (davoceticept) 将检查点拮抗作用与条件性 CD28 共刺激相结合，以产生抗肿瘤免疫力

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-022-29286-5

Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, Dan Ardourel, Chelsea J Gudgeon, Siddarth Chandrasekaran, Sherri L Mudri, Kayla N Kleist, Chris Navas, Martin F Wolfson, Mark W Rixon, Ryan Swanson, Stacey R Dillon, Steven D Levin, Yengo Raymond Kimbung, Masato Akutsu, Derek T Logan, Björn Walse,

Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6

丙型肝炎病毒核心蛋白通过 TLR2、JNK 和 MEK1/2 依赖的 TNF-α 和 IL-6 上调增强人类巨噬细胞中的 HIV-1 复制

期刊:FEBS Letters

影响因子:3

doi:10.1016/j.febslet.2014.08.009

Gokul Swaminathan, Daniel Pascual, Germaine Rival, Renzo Perales-Linares, Julio Martin-Garcia, Sonia Navas-Martin

RNA viruses and microRNAs: challenging discoveries for the 21st century

RNA病毒和microRNA：21世纪的挑战性发现

期刊:Physiological Genomics

影响因子:2.5

doi:10.1152/physiolgenomics.00112.2013

Swaminathan, Gokul; Martin-Garcia, Julio; Navas-Martin, Sonia

微生物学

发表日期：2013

文献求助收藏

MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy

微小RNA、丙型肝炎病毒和HCV/HIV-1合并感染：发病机制和治疗的新见解

期刊:Viruses-Basel

影响因子:3.5

doi:10.3390/v4112485

Gupta, Archana; Swaminathan, Gokul; Martin-Garcia, Julio; Navas-Martin, Sonia

Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges

乙型和丙型肝炎病毒肝癌发生机制：经验教训与未来挑战

期刊:Cancer Letters

影响因子:10.1

doi:10.1016/j.canlet.2010.11.014

Bouchard, Michael J; Navas-Martin, Sonia

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

冠状病毒的发病机制和新出现的病原体严重急性呼吸综合征冠状病毒

期刊:Microbiology and Molecular Biology Reviews

影响因子:7.8

doi:10.1128/MMBR.69.4.635-664.2005

Weiss, Susan R; Navas-Martin, Sonia

微生物学

发表日期：2005

文献求助收藏

Interferon-induced protein ISG15 in the central nervous system, quo vadis?

中枢神经系统中的干扰素诱导蛋白 ISG15，何去何从？

Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein

凝集素与刺突蛋白上的两个聚糖簇结合，导致 SARS-CoV-2 不可逆失活

The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity

工程化的 CD80 变体融合治疗药物达沃西普 (davoceticept) 将检查点拮抗作用与条件性 CD28 共刺激相结合，以产生抗肿瘤免疫力

Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6

丙型肝炎病毒核心蛋白通过 TLR2、JNK 和 MEK1/2 依赖的 TNF-α 和 IL-6 上调增强人类巨噬细胞中的 HIV-1 复制

RNA viruses and microRNAs: challenging discoveries for the 21st century

RNA病毒和microRNA：21世纪的挑战性发现

MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy

微小RNA、丙型肝炎病毒和HCV/HIV-1合并感染：发病机制和治疗的新见解

Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges

乙型和丙型肝炎病毒肝癌发生机制：经验教训与未来挑战

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

冠状病毒的发病机制和新出现的病原体严重急性呼吸综合征冠状病毒